Role of the efflux transporters BCRP and MRP1 in human placental bio-disposition of pravastatin-Reference-Cited by-同舟云学术

Role of the efflux transporters BCRP and MRP1 in human placental bio-disposition of pravastatin

Published:2018-10 Issue: Volume:156 Page:467-478
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Afrouzian Marjan,Al-Lahham Rabab,Patrikeeva Svetlana,Xu Meixiang,Fokina Valentina,Fischer Wayne G.,Abdel-Rahman Sherif Z.,Costantine Maged,Ahmed Mahmoud S.,Nanovskaya Tatiana

Funder

NICHD

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference54 articles.

1. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia;Saad;Reprod. Sci.,2014

2. Effects of pravastatin on mediators of vascular function in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia;Fox;Am. J. Obstet. Gynecol.,2011

3. Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model;Kumasawa;Proc. Natl. Acad. Sci. U.S.A.,2011

4. Using pravastatin to improve the vascular reactivity in a mouse model of soluble FMS-like tyrosine kinase-1-induced preeclampsia;Costantine;Am. J. Obstet. Gynecol.,2010

5. Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension;Bauer;Hypertension,2013

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood–brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics;Expert Opinion on Drug Delivery;2024-01-02

2. Drug Transport Across the Placental Barrier;Oral Bioavailability and Drug Delivery;2023-10-10

3. Mechanisms and Clinical Significance of Pharmacokinetic Drug Interactions Mediated by FDA and EMA-approved Hepatitis C Direct-Acting Antiviral Agents;Clinical Pharmacokinetics;2023-09-20

4. Microfluidic technology and simulation models in studying pharmacokinetics during pregnancy;Frontiers in Pharmacology;2023-08-17

5. Development of a human iPSC-derived placental barrier-on-chip model;iScience;2023-07